Our triple award win at the Industrial Production & Manufacturing Awards 2024 highlights our corporate culture of continuous and meaningful progress towards achieving our Vision. This is evidenced by the Gold Award in the "Excellent Company" category for Pharmaceuticals & Cosmetics, recognizing our central factory in Kryoneri, the Gold Award in the "Investments, Strategy, Innovation in Production" category for Research & Development (R&D), honoring our efforts at the newly established Center for Research and Development of chemical medicines in Thessaloniki and the Silver Award in the "Significant Production Investment" category for our iconic production campus for chemical APIs and medicines in Tripoli. #DemoSA #AlwaysForward #IPMA
DEMO Pharmaceuticals S.A.
Pharmaceutical Manufacturing
Krioneri, Attiki 51,019 followers
Leading quality in injectables
About us
DEMO is a dynamic Greek industrial and commercial organization, specializing in the development, production and supply of pharmaceutical products. The company is the largest supplier of injectables for public hospitals in Greece, exports 80% of its annual production and is recognized as one of the official suppliers of the United Nations, UNICEF, the World Health Organization (WHO), Doctors Without Borders and the International Committee of the Red Cross. With over 3,300 circulation licenses in 86 countries worldwide, the largest factory in SE Europe and over 1,400 employees, DEMO paves the way for pharmaceutical self-sufficiency for Greece and Europe. Today, DEMO implements investments of €356 million, strengthening production and R&D, while entering the development and production of active ingredients and Biotechnology. At the same time, the company is committed to ensuring equality, diversity and inclusion in the working environment and has adopted -within this context- the Diversity Charter for Greece. DEMO moves "Always Forward" driven by its corporate philosophy of providing quality and reliable pharmaceutical products, for everyone. Learn more at www.demo.gr
- Website
-
http://www.demo.gr
External link for DEMO Pharmaceuticals S.A.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Krioneri, Attiki
- Type
- Privately Held
- Specialties
- Generics, Hospital Pharmaceuticals, Injectable Antibiotics, Contract Manufacturing of Pharmaceuticals, pharmaceutical, and biotechnology
Locations
-
Primary
Get directions
21 km National Road Athens-Lamia
Krioneri, Attiki 145 68 , GR
Employees at DEMO Pharmaceuticals S.A.
-
Vassilis Dellopoulos
National Sales Manager at DEMO Pharmaceuticals S.A.
-
Barbara Mouzopoulou
Regulatory Affairs Director
-
Alexios Tsamouris
International Sales Manager Western & Central Europe at DEMO Pharmaceuticals S.A.
-
Nikos Theofanidis, Ph.D.
MSL & Medical Affairs Senior Officer at DEMO Pharmaceuticals S.A.
Updates
-
Overcoming daily challenges within the framework of domestic and global developments, DEMO takes dynamic actions that position Greece as a hub for pharmaceutical research and production. At the same time, it expands its research centers, enhances its production capacity, achieves new milestones such as the production of chemical APIs, and ventures into new fields, such as research activities in Biotechnology. With the arrival of 2025 now being a reality, Mr. Dimitris Demos, CEO of DEMO, highlights: “For 2025, the outlook is optimistic. 2024 concludes with a positive upgrade within the investment category, which, combined with the stable macroeconomic environment we enjoy, further strengthens the growth prospects of our sector.” #DemoSA #AlwaysForward #Quote
-
-
Meet us at the 50th Arab Health 2025! Our company representatives will be attending the international exhibition to discuss the future of healthcare! 🗓️27-30/1 📍Dubai World Trade Centre Learn more: https://bit.ly/42pzNSl #DemoSA #AlwaysForward #M42 #ArabHealth2025 #TheFutureOfHealth
-
-
Fully aligned with the directions of the new EU pharmaceutical policy for the repatriation of medicine production to Europe, through our production hub in Tripoli, we are working towards ensuring our country's adequacy in medicines, Europe's strategic autonomy, and supporting the long-term sustainability of the healthcare system. #DemoSA #AlwaysForward #Tripoli
-
Equipped with modern laboratory infrastructure for chemical organic synthesis of active substances and analytical techniques that support at the same time the field of Organic Synthesis, the new Research & Development center in Thessaloniki is a decisive step for the development of chemical APIs in Greece. Learn more: https://www.demo.gr/ #DemoSA #AlwaysForward #Fact
-
-
Guided by our growth strategy, we are making a significant leap in the field of Biotechnology with investments that are reshaping the pharmaceutical manufacturing landscape in Greece. By establishing the Biologics Manufacturing Sector in Greece from the ground up, we contribute to the country’s Brain Gain, attracting highly skilled scientific talent, collaborating with the scientists of the future, and strengthening domestic production. #DemoSA #AlwaysForward #Biotechnology
-
Our recognition as a TRUE LEADER for 2023 by ICAP CRIF is a testament to our growth strategy during a year full of business challenges. This distinction acknowledges our position among the 500 most profitable companies of 2023, the 500 companies with the largest workforce, and as a leader in our industry based on turnover. Remaining steadfast in our mission, we work daily with a long-term vision, staying true to our motto, looking “Always Forward.” #DemoSA #AlwaysForward #TrueLeaders
-
-
The DEMO team wishes everyone a Happy New Year, filled with health and creativity. For 2025, our guiding compass continues to be our vision: ensuring global access to high-quality medicines, regardless of geographic or economic barriers, as we believe that the right to health should have no borders. #DemoSA #AlwaysForward #HappyNewYear #2025
-
-
During an engaging discussion at the “It’s All About Health” conference, Mr. Demos reflected on the challenges Europe faced during the pandemic in ensuring medicines supply sufficiency. He also emphasized the importance of bringing production back to European territory and highlighted Greece’s potential to become a key reference point for drug autonomy in Europe. #DemoSA #AlwaysForward
-
-
DEMO team wishes Merry Christmas to everyone, filled with health, love, and prosperity! #DemoSA #AlwaysForward #Christmas #MerryChristmas
-